ATE475670T1 - Konsensus-peptid - Google Patents

Konsensus-peptid

Info

Publication number
ATE475670T1
ATE475670T1 AT07866581T AT07866581T ATE475670T1 AT E475670 T1 ATE475670 T1 AT E475670T1 AT 07866581 T AT07866581 T AT 07866581T AT 07866581 T AT07866581 T AT 07866581T AT E475670 T1 ATE475670 T1 AT E475670T1
Authority
AT
Austria
Prior art keywords
consensus peptide
biomineralization
mineralization
stimulation
induction
Prior art date
Application number
AT07866581T
Other languages
English (en)
Inventor
Stale Lyngstadaas
Jan Ellingsen
Original Assignee
Numat As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Numat As filed Critical Numat As
Application granted granted Critical
Publication of ATE475670T1 publication Critical patent/ATE475670T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/14Peptides being immobilised on, or in, an inorganic carrier
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyamides (AREA)
  • Dental Preparations (AREA)
AT07866581T 2006-12-21 2007-12-21 Konsensus-peptid ATE475670T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87614906P 2006-12-21 2006-12-21
PCT/IB2007/004068 WO2008078167A2 (en) 2006-12-21 2007-12-21 Consensus peptide

Publications (1)

Publication Number Publication Date
ATE475670T1 true ATE475670T1 (de) 2010-08-15

Family

ID=39387381

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07866581T ATE475670T1 (de) 2006-12-21 2007-12-21 Konsensus-peptid

Country Status (12)

Country Link
US (1) US8367602B2 (de)
EP (1) EP2118136B1 (de)
JP (1) JP5253412B2 (de)
KR (2) KR20150014999A (de)
AT (1) ATE475670T1 (de)
AU (1) AU2007337797B2 (de)
CA (1) CA2673382C (de)
DE (1) DE602007008147D1 (de)
DK (1) DK2118136T3 (de)
ES (1) ES2349889T3 (de)
PL (1) PL2118136T3 (de)
WO (1) WO2008078167A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5863045B2 (ja) * 2010-03-11 2016-02-16 国立研究開発法人理化学研究所 ポリペプチド配列の選択方法、並びに金属酸化物または含珪素化合物結合ペプチドおよびその利用
US11571584B2 (en) * 2010-12-30 2023-02-07 Frederick R. Guy Tooth and bone restoration via plasma deposition
SE537635C2 (sv) 2012-09-18 2015-08-25 Corticalis As Metod för att producera en alginatbelagd titandioxidscaffold, denna titandioxidscaffold samt medicinskt implantatinnefattande scaffolden
WO2021191903A1 (en) * 2020-03-26 2021-09-30 Bone Sci. Bio Ltd. Pharmaceutical compositions comprising amphiphilic peptides and methods of use thereof
EP4487834A1 (de) * 2023-07-07 2025-01-08 NuPep AS Konsensuspeptide in hya
EP4487863A1 (de) 2023-07-07 2025-01-08 NuPep AS Konsensuspeptide in hya zur verwendung bei der behandlung degenerierter gelenke
WO2025012149A1 (en) * 2023-07-07 2025-01-16 Nupep As Consensus peptides in hya

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108947A0 (en) * 1993-03-12 1994-06-24 Osteopharm Ltd Bone stimulating factor
US5786327A (en) * 1993-03-12 1998-07-28 Gensci Regeneration Sciences Inc. Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same
US7132015B2 (en) * 2002-02-20 2006-11-07 University Of Southern California Materials for dental and biomedical application
JP5069125B2 (ja) * 2004-12-10 2012-11-07 シュトラウマン・ホールディング・アクチェンゲゼルシャフト 新規なタンパク質配合物
WO2006126595A1 (ja) * 2005-05-27 2006-11-30 Japan Science And Technology Agency 機能性材料の三次元構造体

Also Published As

Publication number Publication date
CA2673382C (en) 2016-03-29
JP2010513460A (ja) 2010-04-30
US20100172949A1 (en) 2010-07-08
PL2118136T3 (pl) 2011-04-29
AU2007337797B2 (en) 2012-08-23
CA2673382A1 (en) 2008-07-03
EP2118136A2 (de) 2009-11-18
HK1137186A1 (en) 2010-07-23
EP2118136B1 (de) 2010-07-28
US8367602B2 (en) 2013-02-05
JP5253412B2 (ja) 2013-07-31
WO2008078167A2 (en) 2008-07-03
DK2118136T3 (da) 2010-11-15
WO2008078167A3 (en) 2008-08-21
DE602007008147D1 (de) 2010-09-09
ES2349889T3 (es) 2011-01-12
KR101493437B1 (ko) 2015-02-16
KR20090117702A (ko) 2009-11-12
KR20150014999A (ko) 2015-02-09
AU2007337797A1 (en) 2008-07-03

Similar Documents

Publication Publication Date Title
MY158325A (en) Multitype peptide compositions and methods for treatment or prevention of human papillpmavirus infection
JO2976B1 (en) Axentomodulin polypeptide
MX357801B (es) Agentes dirigidos a gadd45beta.
DK2118136T3 (da) Konsensuspeptid
TN2012000303A1 (en) Oxyntomodulin peptide analogue
DK3323815T3 (en) Human Protein Tyrosine Phosphatase Inhibitors and Methods of Use
MX2009006466A (es) Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina.
EA201000865A1 (ru) Комбинация ингибиторов протеинтирозинфосфатазы и гормона роста человека, предназначенная для лечения атрофии мышц и родственных нарушений
TN2012000512A1 (en) Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
IL196129A0 (en) Human protein tyrosine phosphatase inhibitors and methods of use
ZA200900558B (en) Human protein tyrosine phosphatase inhibitors and methods of use
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
TN2012000511A1 (en) Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
CY1117582T1 (el) Χρηση μιμοτοπων των α-συνουκλεϊνης επιτοπων για θεραπεια ασθενειων σωματος lewy
WO2010135521A3 (en) Compositions and methods for the therapy and diagnosis of influenza
EP2552462A4 (de) Ccn3-peptide und analoge davon zur therapeutischen verwendung
EP2294197A4 (de) Hhip1-proteinvariante sowie verfahren und verwendungen dafür
MX2009005550A (es) Inhibidores de fosfatasa de proteina tirosina para la promocion de la hipertrofia cardiaca fisiologica.
MX2010005280A (es) Nuevos peptidos sinteticos sustituidos con arginina y su uso.
IN2014KN01026A (de)
GB201018125D0 (en) Peptide
ATE489947T1 (de) Axomadol zur schmerzbehandlung bei arthrose
MX2009012599A (es) Mutantes de vegf-d y su uso.
ZA200900492B (en) Human protein tyrosine phosphatase inhibitors and methods of use
ATE505561T1 (de) Gen und polypeptid in zusammenhang mit brustkrebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties